The FDA and Compounding Pharmacies

Published Online: Wednesday, October 23, 2013
Follow Pharmacy_Times:
In this video, shot at the National Community Pharmacists Association 115th Annual Convention in Orlando, David G. Miller, RPh, executive vice president and CEO of the International Academy of Compounding Pharmacists, discusses the roles of the FDA and state boards of pharmacy in regulating compounding pharmacies.

Related Articles
The $200 million fund created to compensate victims of the 2012 meningitis outbreak tied to tainted drugs is an extreme example of how expensive compounding errors can be.
Lipscomb University College of Pharmacy students recently began working in a new sterile compounding laboratory constructed partly in response to the fungal meningitis outbreak in 2012.
The Virginia State Board of Pharmacy shut down the prescription operations of a pharmacy in Richmond after deeming it deficient in several areas upon inspection.
The International Academy of Compounding Pharmacists Board of Directors and the American Pharmacists Association House of Delegates have issued statements discouraging pharmacists from preparing or dispensing products used for lethal injections.
Latest Issues
$auto_registration$